ClinicalTrials.Veeva

Menu

Use of Saliva for COVID-19 Diagnosis (SALIVA-01)

U

University of Milano Bicocca

Status

Completed

Conditions

SARS-CoV2 Infection

Study type

Observational

Funder types

Other

Identifiers

NCT04953039
SALIVA-01

Details and patient eligibility

About

Aim of the study is to evaluate the presence of SARS-CoV2 RNA in the saliva of patients with suspected or confirmed COVID-19 in order to validate the analysis of this type of sample for the diagnosis of SARS-CoV2 infections.

Enrollment

109 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients ≥ 18 years of age hospitalized in the COVID-19 wards of ASST Monza - San Gerardo Hospital with positive, weakly positive or negative nasopharyngeal swabs; initially assessed at the E.R.; symptomatic or asymptomatic with indication to hospitalization.
  • Informed consent freely granted and acquired before the start of the study.

Exclusion criteria

  • Patients with significant clinical conditions which could interfere with the study in the opinion of the researchers.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems